Twitter

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

Condition:   Ovarian Neoplasms
Interventions:   Drug: Carboplatin & paclitaxel;   Biological: Carboplatin & paclitaxel & oregovomab
Sponsors:   Quest PharmaTech Inc.;   Quest PharmaTech Inc.
Recruiting – verified June 2012

Excerpt from: A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer




Comments are closed.